IPO Grey Market Premium: What GMP Is, What It Predicts, and 7 Red Flags

What Is IPO Grey Market Premium?

Before a newly listed stock opens on the NSE or BSE, shares are already changing hands — just not on any exchange you can see. The grey market premium (GMP) is the unofficial price above the IPO issue price at which those shares trade in an entirely unregulated, over-the-counter network of dealers. If a company prices its IPO at ₹450 per share and grey market dealers are quoting a GMP of ₹120, that implies an expected listing price of ₹570 — a 26.7% pop. The number sounds authoritative. It is not.

GMP is not an exchange-traded figure, not audited by SEBI, and not backed by any legal contract. It is a sentiment reading from a parallel market that has operated for decades, mostly out of Gujarat and Mumbai, and has migrated enthusiastically onto Telegram groups and Twitter/X accounts over the last four years. Understanding what GMP actually measures — and what it doesn't — is the only way to use it without getting hurt.

Who Quotes GMP and Where It Comes From

The grey market runs through a loose network of informal IPO dealers, concentrated in Ahmedabad, Surat, and Mumbai's Zaveri Bazaar ecosystem. These dealers take positions in IPO applications before allotment and quote a "kostak" rate (what they'll pay for the application itself) and a per-share GMP. Retail investors who want to exit before listing — or speculate on an allotment they haven't received — transact with these intermediaries on nothing more than trust and reputation.

The quotes then travel fast. A dozen IPO-focused Telegram channels now carry 50,000 to 200,000 subscribers and push live GMP updates multiple times a day. Sites like Chittorgarh and IPOWatch aggregate these numbers and rank IPOs by expected listing gain, which drives enormous search traffic. What those platforms don't tell you is that the number you're reading is one dealer's posted bid, not a market-clearing price. There is no order book. There is no regulator. There is no recourse if the dealer defaults.

How GMP Actually Forms

GMP is not random. It is driven by a specific set of inputs that experienced grey-market participants watch closely:

• Subscription data, especially QIB and HNI buckets. A 200x HNI subscription signals massive leveraged money chasing allotment, which drives GMP up because competition for shares is intense.
• Anchor investor quality. A marquee anchor list — domestic mutual funds, foreign institutional names — signals institutional conviction and pushes GMP higher.
• Sector momentum. Defence, EMS, and capital goods IPOs in FY25 commanded GMP premiums well above their consumer-facing peers simply because secondary market peers were re-rating upward.
• Allotment probability. The lower the allotment chance, the higher the kostak rate and the GMP, because locked-up capital cost is being priced in.
• Post-listing float size. A small public float means tighter supply, which structurally inflates GMP — and also inflates manipulation risk.

These inputs interact in real time. A single large QIB who exits the anchor lock-up window early, or a media report questioning promoter background, can swing GMP by 30–40% in a single afternoon.

What GMP Actually Predicts — The Evidence

The honest answer is: GMP is a reasonable short-term flow signal and a poor quality signal. Studies of Indian IPO data consistently show a moderate positive correlation between closing-day GMP and first-day listing returns — roughly in the 0.55–0.65 range depending on the year and sample. That correlation means something. If every mainboard IPO in a cohort closes with a GMP above 30%, the average first-day pop does tend to land in positive territory.

But that correlation degrades sharply within one to two weeks of listing. By the 30-day mark, GMP has essentially no predictive value for where a stock trades. GMP is a flow signal — it tells you where hot money expects to exit on Day 1. It says nothing about whether the business is worth owning at that price.

The two most cited examples make this concrete. Paytm's November 2021 IPO carried a positive GMP going into listing day. It opened at ₹1,950 against an issue price of ₹2,150 — a 9.3% crash — and kept falling. Grey market dealers had misjudged institutional appetite; the QIB subscription was there, but the secondary market consensus on valuation was brutal. On the other end, LIC's May 2022 IPO came with a muted GMP reflecting weak retail enthusiasm and a complicated macro backdrop. It listed below its issue price of ₹949 and took over a year to recover. Neither miss was a surprise in hindsight — but GMP gave no warning in either direction.

In the SME IPO wave of FY24–25, several issues in the defence components and packaging sectors listed at 80–120% premiums that matched or exceeded GMP predictions on Day 1, then surrendered those gains within a fortnight as market makers withdrew support.

Red Flags: When GMP Is Likely Manipulated

Not all GMP quotes are equal. Watch for these seven warning signs:

• GMP of 80%+ on a weak-quality SME issue with thin subscription across non-HNI categories.
• GMP swinging 50% or more within a single day without any change in subscription data — a sign that one large dealer is setting their own market.
• GMP quoted before subscription pickup is meaningful — if Day 1 overall subscription is 0.3x and GMP is already ₹200, someone is manufacturing enthusiasm.
• No anchor investors but very high GMP — SME IPOs don't require anchors, which removes one quality filter entirely.
• Promoter or company appearing in regulatory actions while GMP stays stubbornly high — retail exit pressure isn't being priced in.
• Kostak rates that exceed the GMP by a wide margin — this means dealers expect allotment-holders to get out, not list and hold.
• GMP quoted only on one or two Telegram channels, not corroborated across multiple independent sources.

Mainboard vs SME GMP: A Different Animal

Mainboard IPO GMP — for issues of ₹1,000 crore and above — is noisier than you'd like but at least reflects a broader dealer network and a deeper institutional order book. SME IPO GMP is a different animal. The float is tiny, market makers have direct incentives to support early trading, and a single promoter-linked entity can technically move prices meaningfully in the first few sessions. SME GMP figures routinely overstate listing gains by 20–40 percentage points in the aggregate, and the variance is enormous. Treating SME GMP with the same confidence as a mainboard GMP is one of the more common — and costly — mistakes retail investors make.

How Experienced Investors Actually Use GMP

Sophisticated IPO investors do read GMP — but as one input among several, never as a standalone signal. The framework looks roughly like this: start with fundamentals (P/E versus listed peers, revenue growth trajectory, margin profile, promoter track record, use of proceeds). Layer on anchor quality — a strong domestic MF anchor list is a genuine signal of institutional diligence. Then check QIB and HNI subscription as an independent demand gauge. GMP enters only after all of that, as a read on Day 1 flow dynamics: is there enough momentum to list at a price where you'd want to book partial profits?

If GMP is high but fundamentals look stretched, that's an exit-on-listing signal, not a hold. If GMP is low but the business is genuinely undervalued relative to peers — rare, but it happens — the grey market's pessimism is an opportunity, not a warning.

Where to Track It — and What's Coming

Right now, the cleanest GMP aggregators are Chittorgarh and IPOWatch. Both carry daily tables, but neither provides the context framework above — you get the number, not the interpretation. Investing.com lists GMP alongside other IPO data but similarly treats it as raw output. Market.news is shipping a live GMP tracker at /ipo/gmp that will integrate real-time subscription data, anchor lists, and our own quality ratings alongside the grey market figure — so you can see the signal and the context in one place. Until that integration goes live, pair whatever GMP number you read with the fundamentals screen outlined above.

For deeper IPO coverage, our full archive lives at /tag/ipo, and the daily India market briefing — which flags notable IPO events in context — is at /briefing/india. GMP is a tool. Like most tools, it hurts when you use it wrong.